Clinical Trial Update: Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluated the combination of lapatinib, carboplatin, and paclitaxel in patients with previously treated ovarian cancer or breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Lapatinib (Lapatinib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Swedish Medical Center | Conditions: Ovarian Epithelial Cancer Stage III, Stage IV Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED